Business CBD Landscape
Tuesday, October 16, 2018
Business is good for hemp-based CBD with 2018 expected to surpass $400Mil in North American sales. However, planning for the next major push into consumer and patient growth for CBD– in its many delivery forms — will prove the next two years is critical for current and expanding hemp and cannabis platforms. Will you be ready? How will the 2018 US Farm Bill interact with the ability for domestic farmers to full enter the market? How will GW Pharma’s entry with their FDA-approved Epidiolex scramble consumer choices? Is clinical research and product innovation able to expand the consumer demand curve? Hear from 18 global experts on 9 panels and solo presentations. And as always, you take home the 4th edition of CBOutlook Sourcebook.
Find more information on www.cboutlook.com